Aurobindo Pharma Ltd - Aurobindo Pharma Limited - Disclosure under SEBI Takeover Regulations
(12 Apr 2024)
K. Nithyananda Reddy on behalf of the promoter and Promoter Reddy has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.